Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COUMADIN for Cerebrovascular accident prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where COUMADIN was used for Cerebrovascular accident prophylaxis.

Most Reported Side Effects for COUMADIN

Side Effect Reports % Deaths Hosp.
International normalised ratio increased 56 18.1% 1 40
Anaemia 22 7.1% 2 20
Drug interaction 21 6.8% 0 19
Fall 20 6.5% 4 15
Contusion 19 6.1% 1 9
Epistaxis 18 5.8% 0 11
Gastrointestinal haemorrhage 18 5.8% 1 16
Diarrhoea 16 5.2% 1 12
Haemorrhage 16 5.2% 0 11
Dyspnoea 14 4.5% 2 8
Cerebrovascular accident 13 4.2% 3 9
Nausea 13 4.2% 1 7
Fatigue 12 3.9% 0 4
Haematuria 11 3.6% 0 7
Pulmonary embolism 11 3.6% 2 10

Other Indications for COUMADIN

Atrial fibrillation (55) Product used for unknown indication (50) Deep vein thrombosis (18) Anticoagulant therapy (10) Thrombosis (10) Pulmonary embolism (8) Cerebrovascular accident (5)

Other Drugs Used for Cerebrovascular accident prophylaxis

RIVAROXABAN (42,963) APIXABAN (36,113) DABIGATRAN ETEXILATE (2,567) XARELTO (1,433) ASPIRIN (878) WARFARIN (519) DIGOXIN (381) BISOPROLOL (351) CLOPIDOGREL BISULFATE (290) PRADAXA (286)

Related Pages

COUMADIN Full Profile All Cerebrovascular accident prophylaxis Drugs COUMADIN Demographics COUMADIN Timeline